tiprankstipranks
Hims & Hers falls -20.7%
PremiumThe FlyHims & Hers falls -20.7%
17h ago
Hims & Hers falls -21.0%
Premium
The Fly
Hims & Hers falls -21.0%
17h ago
Hims & Hers ‘beat and raise story is likely over’ in near-term, says BofA
Premium
The Fly
Hims & Hers ‘beat and raise story is likely over’ in near-term, says BofA
17h ago
Optimistic Buy Rating for Hims & Hers Health Amid Strong FY25 Outlook and Diversified Weight Loss Solutions
PremiumRatingsOptimistic Buy Rating for Hims & Hers Health Amid Strong FY25 Outlook and Diversified Weight Loss Solutions
20h ago
Hims & Hers Health Faces Growth Challenges Amid Mixed Financial Performance: Sell Rating Maintained
Premium
Ratings
Hims & Hers Health Faces Growth Challenges Amid Mixed Financial Performance: Sell Rating Maintained
21h ago
Hims & Hers price target raised to $27 from $25 at Citi
Premium
The Fly
Hims & Hers price target raised to $27 from $25 at Citi
21h ago
Hims & Hers sees Q1 adjusted EBITDA $55M-$65M
PremiumThe FlyHims & Hers sees Q1 adjusted EBITDA $55M-$65M
1d ago
Hims and  Hers Health options imply 17.3% move in share price post-earnings
Premium
The Fly
Hims and Hers Health options imply 17.3% move in share price post-earnings
2d ago
Hims & Hers Health: Navigating Uncertainty with At-Home Lab Testing Expansion
Premium
Ratings
Hims & Hers Health: Navigating Uncertainty with At-Home Lab Testing Expansion
3d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100